Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review
A federal judge Tuesday refused to block filling prescriptions for the abortion pill mifepristone by mail across the U.S. — at least for now.
Summary
On April 7, a federal judge ruled that prescriptions for the abortion pill mifepristone can continue to be filled by mail across the United States. This decision is temporary, as it is contingent on the ongoing review by the FDA.
The judge's ruling highlights the intersection of legal and regulatory frameworks governing pharmaceutical distribution, particularly for medications with significant public health implications.
As the FDA completes its review, stakeholders in the healthcare and pharmaceutical sectors will be closely monitoring any potential changes to the distribution protocols for mifepristone.
Key Facts
| Fact | Value |
|---|---|
| Primary source | STAT |
| Source count | 2 |
| First published | 2026-04-07T22:04:15.000Z |
Updates
Update at 01:52 UTC on 2026-04-08
NPR News reported The abortion pill mifepristone must undergo a safety review by the FDA, the judge said.
Sources: NPR News